Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program. Gary R...
top of page
The Mission
Key Opinion Leaders
International
Advisory Board
Initiatives
Discuss a case
Journal Scan
Latest News
Education Hub
Gallery
IBDENC ENC
- Dec 14, 2022
Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers
Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier. Scott A Jelinsky,...
IBDENC ENC
- Dec 2, 2022
Human Fecal Mucin Glycosylation as a New Biomarker in Inflammatory Bowel Diseases
Catherine Robbe Masselot, Camille Cordier, PharmD, Benjamin Marsac, Maria Nachury, Renaud Léonard, Boualem Sendid Published: 25 November...
IBDENC ENC
- Oct 31, 2022
Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease
Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease by Inducing Host Immune Disorders. Wei Peng, Xinhua Zhao,...
IBDENC ENC
- Oct 29, 2022
Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve
Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease. Sushma Chowdary...
IBDENC ENC
- Oct 28, 2022
An autologous colonic organoid-derived monolayer model to study immune
An autologous colonic organoid-derived monolayer model to study immune: bacterial interactions in Crohn's disease patients. Hamish CK...
IBDENC ENC
- Oct 25, 2022
Effect of risankizumab on health-related quality of life in patients with Crohn's disease
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and...
IBDENC ENC
- Oct 23, 2022
Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease
Benjamin Langan Gordon, Jonathan S Galati, Stevie Yang, Randy S Longman, Dana Lukin, Ellen J Scherl, Robert Battat Published in Sep 2022,...
IBDENC ENC
- Oct 22, 2022
Prediction of Crohn’s Disease Stricturing Phenotype Using a NOD2-derived Genomic Biomarker
James J Ashton, Guo Cheng, Imogen S Stafford, Melina Kellermann, Eleanor G Seaby, J R Fraser Cummings, Tracy A F Coelho, Akshay Batra,...
IBDENC ENC
- Oct 21, 2022
New endoscopic tools in inflammatory bowel disease
Olga Maria Nardone, Rosanna Cannatelli, Subrata Ghosh, Marietta Iacucci Published: 12 October 2022 Abstract Endoscopic remission is now...
IBDENC ENC
- Oct 19, 2022
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the...
IBDENC ENC
- Oct 19, 2022
Real world population pharmacokinetic study in children and young adults with inflammatory bowel
Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool...
bottom of page